Abstract
Due to the high incidence of mammary tumors in dogs, it is important to elucidate the pathogenesis of these tumors in veterinary medicine. Radiation therapy is often used to treat mammary tumors that target DNA lesions. RAD51 is a key molecule that repairs DNA damage via homologous recombination. We examined the relationship between RAD51 expression and radiosensitivity in mammary tumor cell lines. CHMp and CHMm from the same individual were selected based on the differences in RAD51 expression. The radiosensitivity of both cell lines was examined using MTT and scratch assays; CHMm, which has high RAD51 expression, showed higher sensitivity to radiation than CHMp. However, the nuclear focus of RAD51 during DNA repair was formed normally in CHMp, but not in most of CHMm. Since irradiation resulted in the suppression of cell cycle progression in CHMp, the expression of p21, a cell cycle regulatory factor, was detected in CHMp after 15 Gy irradiation but not in CHMm. These results indicate that functional expression is more important than the quantitative expression of RAD51 in canine mammary tumor cells in response to DNA damage.
Funder
Ministry of Education, Culture, Sports, Science, and Technology of Japan
Reference43 articles.
1. Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA;Shinohara;Nat. Genet.,1993
2. RPA and RAD51: Fork reversal, fork protection, and genome stability;Bhat;Nat. Struct. Mol. Biol.,2018
3. Structural basis of homologous recombination;Sun;Cell. Mol. Life Sci.,2020
4. Schipani, F., Manerba, M., Marotta, R., Poppi, L., Gennari, A., Rinaldi, F., Armirotti, A., Farabegoli, F., Roberti, M., and Di Stefano, G. (2022). The mechanistic understanding of RAD51 defibrillation: A critical step in BRCA2-mediated DNA repair by homologous recombination. Int. J. Mol. Sci., 23.
5. RAD51, genomic stability, and tumorigenesis;Richardson;Cancer Lett.,2005